BrainCool
1.882 SEK -4.58%4 investors are following this company
BrainCool develops products used for medical cooling of the human brain. The technology acts as cooling pads that are applied to different part of the patient's body, where the system controls the body temperature and other movements. The products are used in the treatment of various severe conditions such as stroke, cardiac arrest, concussion, and migraine. BrainCool was founded in 2010 and is based in Lund.
Revenue
23.23M
EBIT %
-233.15 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
BRAIN
Daily low / high price
1.734 / 2.08
SEK
Market cap
476.88M SEK
Turnover
956.22K SEK
Volume
517K
Latest videos
Financial calendar
General meeting
2024-06-26
Interim report
2024-08-15
Interim report
2024-11-01
Annual report
2025-02-03
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Avanza Pension | 10.8 % | 10.8 % |
Landia AB | 7.5 % | 7.5 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
BrainCool AB (publ) genomför en företrädesemission om 85,8 MSEK
Correction: BrainCool AB (publ) - Financial Report for Q1 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools